Home Healthcare Healthcare Services Medical Device Testing Market

Medical Device Testing Market Size, Share & Trends Analysis Report By Service Type (Testing Services, Inspection Services, Certification Services), By Testing Type (Physical Testing, Chemical & Biological Testing, Cybersecurity Testing, Microbiology & Sterility Testing), By Phase (Preclinical, Clinical), By Sourcing Type (In-House, Outsourced), By Technology (Active Implant Medical Device, Active Medical Device, Non-Active Medical Device, In-Vitro Diagnostic Medical Device, Others), By Region (North America, Europe, APAC, Middle East and Africa, LATAM), Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:

Medical Device Testing Market Size

The global medical device testing market size was valued at USD 8.52 billion in 2025 and is projected to grow from USD 8.90 billion in 2026 to USD 12.66 billion by 2034, registering a CAGR of 4.5% during the forecast period from 2026 to 2034. North America dominated the medical device testing market with a market share of 38.4% in 2025.

Medical device testing is a series of examinations and assessments to guarantee the safety, efficacy, and quality of medical equipment used in healthcare facilities. These tests are critical for ensuring that medical devices meet regulatory criteria and work as intended. Medical device testing includes various activities, such as biocompatibility testing to assess the device's interaction with biological systems, sterility testing to ensure the absence of viable microorganisms, performance evaluations to evaluate device functionality and durability, and usability testing to assess user interface and human factors.

Market Key Takeaways

Global Market Size & Growth

Testing Services accounts for the largest market share by service type.
Chemical/Biological Testing holds the maximum share of the market by testing type.
The clinical phase influenced the market growth by phase.
In-house generates the highest revenue share by sourcing type.
Active implant medical Devices dominate the market through technology.
Medical Device Testing Market Size

Download a Free Sample To learn more about this report.

Service Analysis

The market by service type is further segmented into Testing Services, Inspection Services, and Certification Services.

Testing services include a thorough review and analysis of medical devices to ensure their safety, efficacy, and compliance with regulatory requirements. These services include a variety of testing procedures, such as biocompatibility testing, sterility testing, performance testing, usability testing, and electrical safety testing, among others. Testing laboratories use specialized equipment, instrumentation, and processes to thoroughly evaluate medical devices, producing data and test results that indicate regulatory compliance. Testing services are critical in guaranteeing the quality and dependability of medical devices throughout their entire lifecycle, from initial development and validation to post-market surveillance and regulatory submissions.

Inspection services include the physical examination and evaluation of medical equipment to ensure they meet specified standards, specifications, and quality criteria. Visual inspections, dimensional measurements, and functional checks are standard services to identify faults, discrepancies, or non-conformities in device design, production, or labeling. Inspection services assist manufacturers in ensuring product integrity, uniformity, and compliance with regulatory requirements, lowering the risk of product recalls, safety accidents, and regulatory punishments. Inspections can occur at several points of the product lifecycle, such as raw material inbound inspection, in-process inspection during manufacturing, and final inspection before product release.

Medical Device Testing Market Size By Segments

Request Customizationto receive a tailored report.

Test Type Analysis

The market can be further bifurcated by testing type into Physical Testing, Chemical/Biological Testing, Cybersecurity Testing, Microbiology, and Sterility Testing.

Chemical and biological testing evaluates medical devices for potential dangers from chemical compounds, biological pollutants, and interactions with biological systems. This includes biocompatibility, cytotoxicity, sensitization, and irritation studies to determine the device's compatibility with living tissues and biological fluids. Chemical testing may also include detecting dangerous substances such as heavy metals, phthalates, and volatile organic compounds (VOCs) to verify product safety and regulatory compliance.

Physical testing evaluates medical devices' mechanical, structural, and material aspects to determine their performance, durability, and safety. This comprises tensile strength, compression testing, impact resistance, wear testing, and dimensional analysis. Physical testing determines the mechanical integrity of medical equipment, ensuring it can survive the pressures and strains during operation. It also ensures that device design, material selection, and manufacturing procedures adhere to specifications and standards.

phase Analysis

The market is fragmented into preclinical and clinical.

The clinical sector had the most significant medical device testing market share in 2023. The segment's growth is attributed to an increase in the product pipeline and the constant upgrading of regulatory criteria. Clinical testing examines medical devices in human subjects to determine their safety, effectiveness, and performance in real-world conditions. Clinical trials are carried out in stages, including early feasibility studies, pivotal trials, and post-market surveillance studies, to show the safety and efficacy of medical devices for their intended clinical applications. The growing emphasis on clinical evidence for new device approvals drives the demand for reliable testing services during clinical trials. Furthermore, the increasing desire of market participants who provide innovative testing procedures at a low cost and with a short turnaround time for a wide range of clinical investigations will likely boost segment expansion.

The preclinical market accounted for 35% in 2023. Preclinical testing studies medical devices in laboratory and animal research to determine safety, effectiveness, and performance before human clinical trials. Preclinical testing collects preliminary data on device operation, biocompatibility, and potential dangers to help design and improve medical devices for human use. Preclinical testing is critical in developing and evaluating medical devices before their approval for human use. The tests are intended to determine the devices' efficacy, safety, and performance to reduce potential dangers and improve patient outcomes in preclinical studies with small and large animals.

Sourcing Type Analysis

The market is sub-segmented into In-house and outsourced.

In-house testing is the practice of carrying out testing activities within the premises of a medical device maker or sponsor organization. In-house testing gives businesses complete control over testing methodologies, quality assurance, and data management. It frequently entails the development of separate testing facilities, complete with specialized equipment, apparatus, and workers skilled in testing procedures. In-house testing provides benefits such as greater control over deadlines, confidentiality of sensitive information, and the ability to modify testing methodologies based on internal requirements. However, establishing and maintaining in-house testing capabilities necessitates significant investment in infrastructure, experience, and regulation compliance.

Outsourced testing is outsourcing activities to third-party testing laboratories, contract research organizations (CROs), or specialized service providers other than the medical device maker. Outsourcing testing services provides various benefits, including access to specialist expertise, cutting-edge facilities, and regulatory compliance support without requiring internal investment in testing infrastructure.

technology Analysis

The market for medical device testing is classified into Active Implant Medical Devices, Active Medical Devices, Non-Active Medical Devices, In-vitro Diagnostic Medical Devices, Ophthalmic Medical Devices, Orthopedic and Dental Medical Devices, and Vascular Medical Devices.

Active implantable medical devices are intended to be inserted into the body and powered by a power source, such as a battery or an external power supply. Pacemakers, ICDs, neurostimulators, and cochlear implants are a few examples. Active implantable medical devices are tested for electrical safety, biocompatibility, performance, and lifespan. Specialized testing techniques, including accelerated life testing and electromagnetic compatibility testing, are frequently required to assure the safety and reliability of these devices.

Active medical devices run on an energy source, such as electricity, and are utilized for diagnostic, monitoring, or therapeutic reasons. Examples include infusion pumps, ventilators, ECG monitors, and blood glucose meters. Active medical equipment is tested for electrical safety, accuracy, reliability, and functionality. Performance testing, calibration, and verification of device settings are required to ensure accurate and consistent measurement or delivery of therapeutic interventions.

Medical Device Testing Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Insights

The global medical device testing market analysis is conducted in North America, Europe, Asia-Pacific, the Middle East and Africa, and Latin America.

North America Dominates the Global Market

North America is the most significant global medical device testing market shareholder and is estimated to grow at a CAGR of 4.8% over the forecast period.Some factors driving market growth in the North American region include a greater emphasis on medical device quality, many companies that serve the medical device industry, well-developed healthcare, and top multinational medical device companies. The Center for Devices and Radiological Health (CDRH) is an FDA division. Class II devices require exceptional controls for 'labeling, guidance, tracking, plan, performance criteria, and post-market observation,' the majority require premarket notification 510(k) to assess substantial equivalence to a lawfully sold device. US healthcare spending is expected to rise by 5% between 2023 and 2024, reaching USD 4.9 trillion. According to the estimate, healthcare spending in the United States will account for 20% of GDP by 2024. Furthermore, as medical devices are increasingly approved in the region, demand for medical device testing services is expected to rise, thereby driving market expansion.

Furthermore, many Original Equipment Manufacturers (OEMs) have focused on electronics manufacturing service providers to properly handle the growing quantities of electronic components in modern medical devices. This has increased demand for medical device testing activities for efficient healthcare in the region, and it is projected to be one of the primary drivers driving medical device testing market growth.

North America Medical Device Testing Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Asia-Pacific: Fastest Growing Region with the Highest Market Cagr

Asia-Pacific is anticipated to exhibit a CAGR of 5.0% over the forecast period, with a 30% revenue share. Rapid developments in healthcare infrastructure and increased regulatory oversight are propelling the region's position in the worldwide medical device testing services market. Furthermore, the expanding demand for various medical device testing methods, favorable pricing models, and the emergence of local manufacturing hubs drive the demand for high-quality testing services, supporting innovation and technological knowledge in the region. Furthermore, cost-effective testing services and the availability of a competent workforce are essential drivers of regional revenue growth.

Additionally, medical device clinical trials in India are driven by increased government financing for R&D to accelerate new product development, making the country a preferred destination for manufacturing services. Outsourcing medical device testing services to emerging countries and increasing clinical trials are expected to drive the worldwide medical device testing services market throughout the forecast period.

The European medical device testing market includes a wide range of testing services and solutions designed to ensure the safety, efficacy, and regulatory compliance of medical devices used in healthcare settings throughout the area. The European Union's Medical Device Regulation (MDR), which went into effect in May 2021, is one of the regulatory requirements driving the European medical device testing industry. The MDR imposes stricter regulations on medical device manufacturers, including increased inspection of clinical evidence, post-market surveillance, and conformity assessment procedures.

List of Key and Emerging Players in Medical Device Testing Market

SGS
Eurofins Scientific
Bureau Veritas
Intertek
Elements Material Technology
Envigo
Avomeen Analytical Services
Gateway Analytical
Medistri SA
North American Science Associates
Pace Analytical Services

Key Industry Developments

April 2026
Eurofins Scientific expanded its medical device testing capabilities by upgrading laboratory infrastructure and adding advanced testing services for connected medical devices, implants, and combination products. The expansion strengthens Eurofins’ support for manufacturers requiring regulatory compliance, safety testing, and performance validation.
February 2026
UL Solutions expanded its healthcare and medical device testing portfolio by introducing enhanced cybersecurity and safety testing services for connected medical devices. The new capabilities support manufacturers developing IoT-enabled medical equipment requiring compliance with evolving safety and digital security requirements.
October 2025
TÜV SÜD expanded its medical device testing and certification capabilities by opening upgraded laboratory facilities focused on active medical devices, software-based medical technologies, and digital health products. The expansion improves testing capacity for manufacturers seeking global regulatory approvals.
June 2025
Intertek Group plc expanded its medical device assurance services by adding advanced biocompatibility, electrical safety, and performance testing capabilities at its healthcare testing laboratories. The expansion supports medical device manufacturers throughout product development and regulatory submission processes.

Report Scope

Segmentation

By Service Type 3
  • Testing Services
  • Inspection Services
  • Certification Services
By Testing Type 4
  • Physical testing
  • Chemical and biological testing
  • Cybersecurity testing
  • Microbiology and sterility testing
By Phase 2
  • Preclinical
  • Clinical
By Sourcing Type 2
  • In-house
  • Outsourced
By Technology 7
  • Active Implant Medical Device
  • Active Medical Device
  • Non-Active Medical Device
  • In-vitro Diagnostic Medical Device
  • Ophthalmic Medical Device
  • Orthopedic and Dental Medical Devices
  • Vascular Medical Device

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 8
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Singapore
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage SGS · Eurofins Scientific · Bureau Veritas · Intertek · Elements Material Technology
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The medical device testing market size is valued at USD 8.90 Billion in 2026 and is projected to reach USD 12.66 Billion by 2034, at a CAGR of 4.5% during the forecast period 2026-2034.

North America dominated the market with a share of 38.4% in 2025.

The leading players in this market are SGS, Eurofins Scientific, Bureau Veritas, Intertek, Elements Material Technology.

The medical device testing market is projected to grow at a CAGR of 4.5% during the forecast period of 2026 2034.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now

We are featured on: